Cargando…

RNase III nucleases from diverse kingdoms serve as antiviral effectors

In contrast to the DNA-based viruses in prokaryotes, the emergence of eukaryotes provided the necessary compartmentalization and membranous environment for RNA viruses to flourish, creating the need for an RNA-targeting antiviral system(1,2). Present day eukaryotes employ at least two main defense s...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguado, Lauren C., Schmid, Sonja, May, Jared, Sabin, Leah R., Panis, Maryline, Blanco-Melo, Daniel, Shim, Jaehee V., Sachs, David, Cherry, Sara, Simon, Anne E., Levraud, Jean-Pierre, tenOever, Benjamin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846625/
https://www.ncbi.nlm.nih.gov/pubmed/28658212
http://dx.doi.org/10.1038/nature22990
Descripción
Sumario:In contrast to the DNA-based viruses in prokaryotes, the emergence of eukaryotes provided the necessary compartmentalization and membranous environment for RNA viruses to flourish, creating the need for an RNA-targeting antiviral system(1,2). Present day eukaryotes employ at least two main defense strategies that emerged as a result of this viral shift, namely antiviral RNA interference (RNAi) and the interferon (IFN) system(2). Here, we demonstrate that Drosha and related RNase III ribonucleases from all three domains of life, also elicit RNA-targeting antiviral activity. Systemic evolution of ligands by exponential enrichment (SELEX) on this class of proteins illustrates the recognition of unbranched RNA stem loops. Biochemical analyses reveal that in this context, Drosha functions as an antiviral clamp, conferring steric hindrance on the RNA dependent RNA polymerases (RdRps) of diverse positive stranded RNA viruses. We present evidence for cytoplasmic translocation of RNase III nucleases in response to virus in diverse eukaryotes including: plants, arthropods, invertebrate chordates, and fish. These data implicate RNase III recognition of viral RNA as an antiviral defense that is independent of, and possibly predates, other known eukaryotic antiviral systems.